- Home
- IBRX vs XP Comparison
IBRX vs XP Comparison
Compare IBRX & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBRX | XP |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.4B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IBRX | XP |
|---|---|---|
| Price | $7.63 | $16.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $12.57 | ★ $23.17 |
| AVG Volume (30 Days) | ★ 8.5M | 4.2M |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $88.59 | $19.00 |
| Revenue Next Year | $131.15 | $13.64 |
| P/E Ratio | ★ N/A | $11.42 |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $14.80 |
| 52 Week High | $12.43 | $23.13 |
Technical Indicators
Market Signals| Indicator | IBRX | XP |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 56.55 |
| Support Level | $6.68 | $16.23 |
| Resistance Level | $8.46 | $17.22 |
| Average True Range (ATR) | 0.33 | 0.58 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 58.28 | 74.15 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.